Einige Inhalte auf dieser Seite sind in deutscher Sprache nicht verfügbar und werden automatisch in derzeit verfügbarer Sprache angezeigt.

Palbociclib

Artikel-Nr.	Packungseinheit	Preis	Vorlaufzeit	Jetzt kaufen
5250-1g	1 g	$399.00	12 Tagen.
5250-5g	5 g	$1296.00	12 Tagen.

Einen günstigeren Preis gefunden? Lassen Sie es uns wissen und wir unterbreiten Ihnen ein besseres Angebot!

Palbociclib is a reversible, highly selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). The drug is used exclusively in combination with other agents for the treatment of hormone receptor-positive, HER2-negative advanced-stage breast cancer (depending on the line of therapy, it is combined with letrozole, anastrozole, or fulvestrant). As a first-in-class targeted therapy, it was granted FDA approval on February 3, 2015. Palbociclib is also employed in preclinical and clinical research to evaluate its efficacy against other cancer types and to investigate mechanisms of acquired resistance to targeted therapy.

This product is intended for research use only.

Herunterladen im
ChemDraw-Format

General properties

Appearance:	yellow solid
Molecular weight:	447.54
CAS number:	571190-30-2
Molecular formula:	C₂₄H₂₉N₇O₂
Solubility:	chloroform, DMSO, methanol
Quality control:	NMR ¹H and HPLC-MS (98+%)
Storage conditions:	24 months after receival at -20°C in the dark. Transportation: at room temperature for up to 3 weeks. Desiccate.
Sicherheitsdatenblatt:	herunterladen
	Product specifications